Answer
Empliciti (elotuzumab), combined with lenalidomide and dexamethasone, treats multiple myeloma in adults who have received at least one prior therapy.
Sources for this answer
- Empliciti 300 mg and 400 mg powder for concentrate for solution for infusionBristol Myers Squibb Pharmaceuticals limited · emc · SmPC §4.1 Therapeutic Indications · Version 12Document updated
Sources checked